comparemela.com

Latest Breaking News On - Novartis gene therapies inc - Page 1 : comparemela.com

Drug control authority approves product registration of Zolgensma, Qdenga

PUTRAJAYA The 393rd Drug Control Authority meeting on Friday (Feb 8) approved the registration of Zolgensma, a cell and gene therapy product, for the first time since the product's control came into force on Jan 1, 2021.

Germany
Malaysia
United-states
Malaysian
Takeda-gmb
Sdn-bhd
Muhammad-radzi-abu-hassan
Muhammad-radzi
National-pharmaceutical-regulatory-agency
Novartis-gene-therapies-inc
Novartis-corporation-malaysia-sdn-bhd
Drug-control-authority

Health Alert for Parents: How one boy is thriving following treatment with a gene therapy after receiving an early diagnosis

Health Alert for Parents: How one boy is thriving following treatment with a gene therapy after receiving an early diagnosis
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states
Katie-lesch
Novartis-gene-therapies-inc
Global-medical-affairs-at-novartis-gene-therapies
Multichannel-news-release
Full-prescribing
Newborn-screening-awareness-month
Sandra-reyna
Vice-president
Global-medical-affairs
Novartis-gene-therapies
Hannah-weaver

Global Gene Therapies For Rare Diseases Market worth $ 11.4 Billion by 2030 - Exclusive Report by InsightAce Analytic

Global Gene Therapies For Rare Diseases market is expected to reach US$ 11,441.6 Million by 2030, with a CAGR of 21.7% during a forecast period of 2022-2030.

Japan
United-states
Brazil
China
Kolon
Krasnoyarskiy-kray
Russia
Beijing
South-africa
Anchiano
Toscana
Italy

vimarsana © 2020. All Rights Reserved.